These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33260)

  • 1. Effects of drugs on the formation of 3-methoxytyramine, a dopamine metabolite, in the substantia nigra, striatum, nucleus accumbens and tuberculum olfactorium of the rat.
    Westerink BH
    J Pharm Pharmacol; 1979 Feb; 31(2):94-9. PubMed ID: 33260
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine metabolism in the tuberculum olfactorium.
    Wilk S; Watson E; Glick SD
    Eur J Pharmacol; 1975 Jan; 30(1):117-20. PubMed ID: 1122932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between plasma homovanillic acid and indices of dopamine turnover in multiple brain areas during haloperidol and saline administration.
    Csernansky JG; Barnes DE; Bellows EP; Lombrozo L
    Life Sci; 1990; 46(10):707-13. PubMed ID: 2314192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine release in substantia nigra?
    Korf J; Zieleman M; Westerink BH
    Nature; 1976 Mar; 260(5548):257-8. PubMed ID: 1256566
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative biochemical and behavioural effects of fencamfamine and dl-amphetamine in rats.
    Aizenstein ML; Scavone C; Bernardi MM; Delucia R
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):187-94. PubMed ID: 6684314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of dopamine metabolism in solid fetal substantia nigra transplants and their terminals in the host striatum.
    Meloni R; Gale K
    Prog Brain Res; 1990; 82():467-71. PubMed ID: 2127112
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatodendritic release of endogenous dopamine: in vivo dialysis in the A10 dopamine region.
    Kalivas PW; Bourdelais A; Abhold R; Abbott L
    Neurosci Lett; 1989 May; 100(1-3):215-20. PubMed ID: 2761771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D1 receptor in rat brain: a quantitative autoradiographic study with 125I-SCH 23982.
    Aiso M; Shigematsu K; Kebabian JW; Potter WZ; Cruciani RA; Saavedra JM
    Brain Res; 1987 Apr; 408(1-2):281-5. PubMed ID: 2954614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1-methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain.
    Antkiewicz-Michaluk L; Karolewicz B; Romańska I; Michaluk J; Bojarski AJ; Vetulani J
    Eur J Pharmacol; 2003 Apr; 466(3):263-9. PubMed ID: 12694809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphine stimulation of mesolimbic and mesocortical but not nigrostriatal dopamine release in the rat as reflected by changes in 3-methoxytyramine levels.
    Wood PL; Rao TS
    Neuropharmacology; 1991 Apr; 30(4):399-401. PubMed ID: 1852270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors.
    Trout SJ; Kruk ZL
    Br J Pharmacol; 1992 Jun; 106(2):452-8. PubMed ID: 1393270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic modulation of dopamine release in corpus striatum and substantia nigra of the rat.
    Marchi M; Volpe G; Augliera A; Codignola A; Lunardi G; Raiteri M
    Neurochem Int; 1992 Mar; 20 Suppl():271S-274S. PubMed ID: 1365441
    [No Abstract]   [Full Text] [Related]  

  • 14. Regional effects of neuroleptics on dopamine metabolism and dopamine-sensitive adenylate cyclase activity.
    Scatton B; Bischoff S; Dedek J; Korf J
    Eur J Pharmacol; 1977 Aug; 44(4):287-92. PubMed ID: 19266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of centrally acting drugs on regional dopamine metabolism.
    Westerink BH
    Adv Biochem Psychopharmacol; 1978; 19():255-66. PubMed ID: 358781
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro uptake of 3-methoxytyramine by rat brain tissue slices.
    Gordon JH; Shellenberger MK
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):33-46. PubMed ID: 841182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topography of substantia nigra innervation by D1 receptor-containing striatal neurons.
    Altar CA; Hauser K
    Brain Res; 1987 Apr; 410(1):1-11. PubMed ID: 2953407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurochemical investigations of the interaction of N,N-dimethyltryptamine with dopaminergic system in rat brain.
    Waldmeier PC; Maître L
    Psychopharmacology (Berl); 1977 Apr; 52(2):137-44. PubMed ID: 407597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.